• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2022 State of Cancer Survivorship Survey
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • 2022 Winners
      • Awardees
      • Reception and Sponsorship
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

NCCS Starburst 250px

What Caught Our Eye: ‘Extremely High Premiums’ for the Sick, AHCA News, FDA Aims to Control Rx Pricing, & More

May 26, 2017/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Drug Pricing, Financial Toxicity, Health Equity, Pre-Existing Conditions, Quality Cancer Care NCCS News /by actualize
What Caught Our Eye (WCOE), May 26, 2017
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

In the Spotlight

“Millions Of Ill People May Face ‘Extremely High Premiums’ Under House Bill, CBO Says”

Millions of ill people may face ‘extremely high premiums’ under House bill, CBO says https://t.co/qhKoh9voj4 pic.twitter.com/yJvTTivC9y

— Kaiser Health News (@KHNews) May 24, 2017

Via Kaiser Health News — The Republican overhaul of the federal health law passed by the House this month would result in slightly lower premiums and slightly fewer uninsured Americans than an earlier proposal. But it would leave as many as one-sixth of Americans living in states where older and sicker people might have to pay much more for their health care or be unable to purchase insurance at all, the Congressional Budget Office said Wednesday.
Read More »


Affordable Care Act

“Republican health care bill fails the Jimmy Kimmel test. Again.”

My column: As America get closer, DC gets further away.

Republican health care bill fails Jimmy Kimmel test. Again. https://t.co/x67DMk3tMR

— Andy Slavitt @ 🏡 (@ASlavitt) May 24, 2017

Via USA Today — Given our divisions, it’s often hard to imagine reaching a consensus in this country on anything. Yet polls show Americans are increasingly aligning behind the Kimmel test, in favor of universal and affordable coverage ensured by the government.
Read More »

“Three Strategies to Defend GOP Health Bill: Euphemisms, False Statements and Deleted Comments”

Three strategies to defend the GOP Health Bill: euphemisms, false statements and deleted comments https://t.co/KtnUGWHwLK

— ProPublica (@propublica) May 25, 2017

Via ProPublica — As Republican members of Congress seek to roll back the Affordable Care Act, commonly called Obamacare, and replace it with the American Health Care Act, they have adopted various strategies to influence and cope with public opinion, which polls show mostly opposes their plan. ProPublica, with our partners at Kaiser Health News, Stat and Vox, has been fact-checking members of Congress in this debate and we’ve found misstatements on both sides, though more by Republicans than Democrats. The Washington Post’s Fact Checker has similarly found misstatements by both sides.
Read More »

“Blue Cross Plan Puts 23% Obamacare Rate Hike On GOP Congress”

"If the federal funding continued, we would have filed an average increase of just 8.8 percent for 2018," @BCBSNC https://t.co/D7kB5ZQiQs

— Bruce Japsen (@brucejapsen) May 25, 2017

Via Forbes.com — “The biggest single reason for the sharp increase in rates is the lack of federal funding for cost-sharing reductions beginning in 2018,” North Carolina Blue Cross director of actuarial and pricing services Brian Tajlili wrote on the insurer’s web site Thursday.
Read More »

Cancer Policy

“Trump’s proposed budget would cripple the NIH and FDA”

Sigal: Trump’s proposed budget would cripple the #NIH and #FDA via @statnews https://t.co/tdl2NLeihw

— Cancer Research (@CancerResrch) May 24, 2017

Via Stat News — Ellen Sigal, founder of Friends of Cancer Research, writes:

“At best, the proposed budget suggests that the White House doesn’t understand how the NIH and the FDA function. At worst, it suggests a disregard for the millions of patients who are desperate for the scientific innovations, lifesaving therapies, and safeguards that emerge from these agencies.”
Read More »


“FDA Chief Proposes Rules Changes to Fight High Drug Prices”

New FDA head plans a more active role in restraining high prices of prescription drugs https://t.co/6bdgNmHrep

— The Wall Street Journal (@WSJ) May 25, 2017

Via Wall Street Journal — “Simply put, too many patients are priced out of the medicines they need,” [FDA Commissioner] Dr. [Scott] Gottlieb told a congressional subcommittee Thursday. “While the FDA does not have a direct role in drug pricing, we can take steps to facilitate entry of lower-cost alternatives to the market, and increase competition.”
Read More »

“In Bold Move, FDA Approves Cancer Drug For Any Advanced Tumor With Genetic Changes”

Bold move! FDA Approves Keytruda For Any Advanced Cancer w/ Certain Genetic Changes, @Forbes – https://t.co/cAtl46Fy9w #PrecisionMedicine

— Elaine Schattner MD, MA (@ESchattner) May 23, 2017

Via Forbes.com — The FDA’s accelerated approval of this drug might surprise traditional oncologists. It suggests the agency may be ditching an archaic system for classifying cancers based on body parts—like breast or liver or colon cancer—and instead will focus on molecular aspects of malignancies, qualities that render tumors vulnerable, or not, to targeted drugs.
Read More »

Coping with Cancer

“Counseling Improves Survivorship Plan Implementation for Low-Income Breast Cancer Survivors”

Counseling #breastcancer survivors about their #survivorship care plans may help their doctors provide better care https://t.co/YiQC6Cn6dh pic.twitter.com/EGccStIak2

— National Cancer Institute (@theNCI) May 25, 2017

Via National Cancer Institute (NCI) — “The nurse counseling session was empowering [for the survivors], who were from a vulnerable population that is generally disempowered in their health care,” explained the study’s lead author, Rose Maly, M.D., of the UCLA Jonsson Comprehensive Cancer Center. The combination of a care plan and the counseling session, she continued, “set this up to be a powerful and impactful intervention,” she said.
Read More »

More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy


Tags: affordable care act, AHCA, breast cancer, cancer care, care planning, cost of care, costs, drug approvals, drug pricing, FDA, financial issues, pre-existing conditions, What Caught Our Eye
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png 250 250 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2017-05-26 12:54:532017-05-26 12:54:53What Caught Our Eye: ‘Extremely High Premiums’ for the Sick, AHCA News, FDA Aims to Control Rx Pricing, & More

Latest News

NCCS Urges President Biden and Congress to Support and Protect Medicaid

March 24, 2023
This week, NCCS joined with more than 30 patient advocacy organizations as part of the Partnership to Protect Coverage to urge President…
Read more
https://canceradvocacy.org/wp-content/uploads/Medicaid-Protect-Letter-Congress-Blog.png 628 1200 Kara Kenan https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png Kara Kenan2023-03-24 15:51:462023-03-24 15:51:46NCCS Urges President Biden and Congress to Support and Protect Medicaid

NCCS Advocates for Access to DIEP Flap Breast Reconstruction Surgery

March 10, 2023
The National Coalition for Cancer Survivorship recently joined the Community Breast Reconstruction Alliance (CBRA), a group of patient…
Read more
https://canceradvocacy.org/wp-content/uploads/Diane-Heditsian-PBS-Newshour-DIEP-Flap.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-03-10 13:24:422023-03-10 13:28:53NCCS Advocates for Access to DIEP Flap Breast Reconstruction Surgery
NCCS Advocate Spotlight: Betsy Glosik, A Cancer Survivor's Journey Through Integrative Healing and Advocacy

Betsy Glosik: A Cancer Survivor’s Journey Towards Integrative Healing and Advocacy

March 8, 2023
For Betsy Glosik, the early 2000s brought one trauma after another. She lost her aunt to melanoma. Then, tragically she lost her 20-yr old daughter to a car accident. In 2003, after years of mentioning her concerns about a mole on her foot to her dermatologist, and repeatedly having her concerns dismissed, Betsy was diagnosed with melanoma...
Read more
https://canceradvocacy.org/wp-content/uploads/Betsy-Glosik-Advocate-Spotlight-Blog-Banner.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-03-08 12:55:132023-03-08 12:55:13Betsy Glosik: A Cancer Survivor’s Journey Towards Integrative Healing and Advocacy

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2022 State of Cancer Survivorship Survey
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • 2022 Winners
      • Awardees
      • Reception and Sponsorship
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

NCCS Statement on CBO Report of Revised American Health Care Act Fotolia 23428619 S e1461260836640 ProtectOurCare 1024px ACA Update | May 26, 2017: CBO Confirms 23 Million More Uninsured Under AHCA,...
Scroll to top
Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute